its insurance concierge helps determine coverage for GLP-1 medications, which are billed separately
has advisory roles (compensated, institutional) with Boehringer Ingelheim and MSD, receives research support (institutional) from AstraZeneca and Bristol-Myers Squibb (BMS), and receives travel support for medical conferences from Boehringer Ingelheim, MSD and Takeda
Tirzepatide has established proof-of-concept for the GIP/GLP-1 receptor agonist mechanism of action, but the pipeline extends further
Skin penetration depends on formulation, concentration, and application technique
These changes tend to be progressive, not overnight, which fits the clinic's focus on sustainable, science-based results
If you experience side effects like chest discomfort, our specialists are available to help you determine the next steps, adjust your dosage if necessary, or provide guidance on managing symptoms